
SenseTime Group (20)
1.41 HKD -0.08 (-5.37%) Volume: 445.16M
SenseTime Group’s stock price stands at 1.41 HKD, experiencing a drop of -5.37% this trading session with a trading volume of 445.16M, mirroring its YTD performance with the same percentage decline, highlighting the company’s stock market volatility.
Latest developments on SenseTime Group
SenseTime Group, the leading Chinese AI company, has recently shared new insights into their innovative 24-Hour AI ALS Care System. This announcement has sparked investor interest and led to fluctuations in SenseTime Group’s stock price today. The company’s commitment to developing cutting-edge AI technologies for healthcare applications has garnered attention from shareholders, causing excitement about the potential growth prospects for SenseTime Group in the future.
A look at SenseTime Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 1 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, SenseTime Group has a positive long-term outlook. With high scores in Growth and Value, the company is positioned for strong performance in the future. SenseTime Group’s focus on developing artificial intelligence and computer vision software products aligns well with the growing demand for these technologies.
Although SenseTime Group has a lower score in Dividend, its high scores in Momentum and Resilience indicate that the company is well-positioned to weather any challenges that may arise. Overall, SenseTime Group’s innovative products and services, coupled with its strong growth potential, make it a company to watch in the coming years.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars